Targovax ASA announced that Erik Digman Wiklund has been appointed as the company's new Chief Financial Officer, and will take up this role in April 2017. The previous CFO, Oystein Soug, was appointed as the company's CEO on 2 November 2016. Erik joins from the nutraceutical company Aker Biomarine Antarctic AS, where he held the position as Director of Product Innovation. Prior to joining Aker Biomarine, Erik worked for Norwegian cancer biotechnology company Algeta ASA, and also has management consulting experience from the Pharma & Health Care practice of McKinsey & Company.